January 5th, 2012
Mirador Biomedical receives 510(k) clearance for expanded Compass Platform, launches Thoracentesis and Compartment Pressure monitoring products
July 28th, 2011
Mirador Biomedical receives CE Mark for its Compass Point-of-Access Pressure Measurement Device Platform
January 31st, 2011
Mirador Biomedical closes $1.5 million Series B Round of Funding
June 2nd, 2010
Mirador Biomedical submits 510(k)
Mirador Biomedical submits 510(k) application for Compass Vascular Access device
March 2nd, 2010
Mirador Biomedical closes Series A funding
Mirador Biomedical closes $1.1 million Series A round of funding (PDF)
March 2nd, 2010
John Harris appointed to Board of Directors
October 2nd, 2009
